Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
27.73
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT
TKPHF Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 4,417,004 | 4,581,551 | 4,263,762 | 4,027,478 | 3,569,006 | 3,197,812 | Upgrade | |
Revenue Growth (YoY) | -2.84% | 7.45% | 5.87% | 12.85% | 11.61% | -2.84% | Upgrade |
Cost of Revenue | 1,554,890 | 1,571,419 | 1,431,505 | 1,253,163 | 1,127,308 | 1,013,655 | Upgrade |
Gross Profit | 2,862,114 | 3,010,132 | 2,832,257 | 2,774,315 | 2,441,698 | 2,184,157 | Upgrade |
Selling, General & Admin | 1,075,856 | 1,104,732 | 1,053,819 | 997,234 | 886,327 | 875,514 | Upgrade |
Research & Development | 691,572 | 730,226 | 728,617 | 633,325 | 526,087 | 455,765 | Upgrade |
Amortization of Goodwill & Intangibles | 531,454 | 548,186 | 521,525 | 485,102 | 418,789 | 405,229 | Upgrade |
Other Operating Expenses | 77,131 | 64,052 | 28,821 | 38,987 | 10,433 | 23,602 | Upgrade |
Operating Expenses | 2,376,013 | 2,447,196 | 2,332,782 | 2,154,648 | 1,841,636 | 1,760,110 | Upgrade |
Operating Income | 486,101 | 562,936 | 499,475 | 619,667 | 600,062 | 424,047 | Upgrade |
Interest Expense | -210,938 | -130,487 | -115,392 | -116,973 | -122,432 | -130,806 | Upgrade |
Interest & Investment Income | 102,865 | 19,983 | 11,628 | 5,781 | 4,763 | 2,153 | Upgrade |
Earnings From Equity Investments | -5,354 | -3,986 | 6,473 | -8,630 | -15,367 | 76 | Upgrade |
Currency Exchange Gain (Loss) | 786 | 786 | -13,612 | -9,729 | -3,903 | -15,575 | Upgrade |
Other Non Operating Income (Expenses) | -24,866 | -24,865 | -31,520 | 3,975 | -26,119 | 1,118 | Upgrade |
EBT Excluding Unusual Items | 348,594 | 424,367 | 357,052 | 494,091 | 437,004 | 281,013 | Upgrade |
Merger & Restructuring Charges | -93,932 | -128,133 | -81,358 | -59,234 | -83,836 | -115,875 | Upgrade |
Gain (Loss) on Sale of Investments | -585 | -18,885 | - | 22,416 | 8,482 | - | Upgrade |
Gain (Loss) on Sale of Assets | 4,461 | 10,561 | 7,975 | 8,901 | 8,164 | 235,117 | Upgrade |
Asset Writedown | -151,659 | -103,379 | -146,047 | -62,484 | -54,421 | -17,521 | Upgrade |
Legal Settlements | - | - | -45,212 | -16,455 | -20,319 | -17,401 | Upgrade |
Other Unusual Items | -8,968 | -9,447 | -39,619 | -12,145 | 7,497 | 902 | Upgrade |
Pretax Income | 97,911 | 175,084 | 52,791 | 375,090 | 302,571 | 366,235 | Upgrade |
Income Tax Expense | 64,625 | 66,941 | -91,406 | 58,052 | 72,405 | -9,936 | Upgrade |
Earnings From Continuing Operations | 33,286 | 108,143 | 144,197 | 317,038 | 230,166 | 376,171 | Upgrade |
Minority Interest in Earnings | -211 | -215 | -130 | -21 | -107 | -166 | Upgrade |
Net Income | 33,075 | 107,928 | 144,067 | 317,017 | 230,059 | 376,005 | Upgrade |
Net Income to Common | 33,075 | 107,928 | 144,067 | 317,017 | 230,059 | 376,005 | Upgrade |
Net Income Growth | -88.59% | -25.09% | -54.55% | 37.80% | -38.81% | 749.90% | Upgrade |
Shares Outstanding (Basic) | 1,576 | 1,579 | 1,564 | 1,552 | 1,564 | 1,562 | Upgrade |
Shares Outstanding (Diluted) | 1,604 | 1,605 | 1,580 | 1,570 | 1,577 | 1,574 | Upgrade |
Shares Change (YoY) | 0.65% | 1.58% | 0.67% | -0.46% | 0.23% | 0.47% | Upgrade |
EPS (Basic) | 20.98 | 68.36 | 92.09 | 204.29 | 147.14 | 240.72 | Upgrade |
EPS (Diluted) | 20.62 | 67.23 | 91.16 | 201.94 | 145.87 | 238.96 | Upgrade |
EPS Growth | -88.67% | -26.25% | -54.86% | 38.44% | -38.96% | 745.88% | Upgrade |
Free Cash Flow | 1,017,677 | 856,387 | 540,924 | 836,499 | 999,853 | 899,725 | Upgrade |
Free Cash Flow Per Share | 634.60 | 533.47 | 342.28 | 532.85 | 633.95 | 571.78 | Upgrade |
Dividend Per Share | 198.000 | 196.000 | 188.000 | 180.000 | 180.000 | 180.000 | Upgrade |
Dividend Growth | 3.13% | 4.25% | 4.44% | - | - | - | Upgrade |
Gross Margin | 64.80% | 65.70% | 66.43% | 68.88% | 68.41% | 68.30% | Upgrade |
Operating Margin | 11.00% | 12.29% | 11.71% | 15.39% | 16.81% | 13.26% | Upgrade |
Profit Margin | 0.75% | 2.36% | 3.38% | 7.87% | 6.45% | 11.76% | Upgrade |
Free Cash Flow Margin | 23.04% | 18.69% | 12.69% | 20.77% | 28.02% | 28.14% | Upgrade |
EBITDA | 1,138,373 | 1,233,262 | 1,143,936 | 1,284,067 | 1,183,213 | 983,718 | Upgrade |
EBITDA Margin | 25.77% | 26.92% | 26.83% | 31.88% | 33.15% | 30.76% | Upgrade |
D&A For EBITDA | 652,272 | 670,326 | 644,461 | 664,400 | 583,151 | 559,671 | Upgrade |
EBIT | 486,101 | 562,936 | 499,475 | 619,667 | 600,062 | 424,047 | Upgrade |
EBIT Margin | 11.00% | 12.29% | 11.71% | 15.39% | 16.81% | 13.26% | Upgrade |
Effective Tax Rate | 66.00% | 38.23% | - | 15.48% | 23.93% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.